STOCK TITAN

Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Stevanato Group (NYSE: STVN), a leading provider of drug containment, delivery, and diagnostic solutions, has announced its plans to release second quarter 2024 financial results on August 6, 2024, at 6:30 a.m. ET. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. Management will refer to a slide presentation available on the company's website. Participants can pre-register for the call or dial in directly. A live webcast will be available, and the call will be archived for three months on the company's Investor Relations website.

Stevanato Group (NYSE: STVN), un fornitore leader di soluzioni per il contenimento, la somministrazione e la diagnostica dei farmaci, ha annunciato i suoi piani per pubblicare i risultati finanziari del secondo trimestre 2024 il 6 agosto 2024 alle 6:30 a.m. ET. L'azienda ospiterà una conferenza telefonica e una webcast il 6 agosto alle 8:30 a.m. ET per discutere i risultati. La direzione farà riferimento a una presentazione slide disponibile sul sito web dell'azienda. I partecipanti possono registrarsi in anticipo per la chiamata o comporre direttamente il numero. Sarà disponibile una webcast in diretta e la chiamata sarà archiviata per tre mesi sul sito web delle Relazioni con gli Investitori dell'azienda.

Stevanato Group (NYSE: STVN), un proveedor líder de soluciones para el almacenamiento, la entrega y el diagnóstico de medicamentos, ha anunciado sus planes para publicar los resultados financieros del segundo trimestre de 2024 el 6 de agosto de 2024 a las 6:30 a.m. ET. La empresa realizará una conferencia telefónica y una transmisión web el 6 de agosto a las 8:30 a.m. ET para discutir los resultados. La dirección hará referencia a una presentación en diapositivas disponible en el sitio web de la empresa. Los participantes pueden registrarse previamente para la llamada o marcar directamente. Se dispondrá de una transmisión web en vivo, y la llamada se archivará durante tres meses en el sitio web de Relaciones con Inversores de la empresa.

Stevanato Group (NYSE: STVN)는 약물 보관, 전달 및 진단 솔루션의 선도적인 제공업체로, 2024년 2분기 재무 결과2024년 8월 6일 오전 6:30 (ET)에 발표할 계획이라고 발표했습니다. 회사는 같은 날 오전 8:30 (ET)에 결과를 논의하기 위한 컨퍼런스 콜 및 웹캐스트를 개최할 예정입니다. 경영진은 회사 웹사이트에서 제공되는 슬라이드 발표를 참고할 것입니다. 참가자는 사전에 예약할 수 있으며, 직접 전화할 수도 있습니다. 라이브 웹캐스트가 제공되며, 콜은 회사의 투자자 관계 웹사이트에 3개월 동안 보관됩니다.

Stevanato Group (NYSE: STVN), un fournisseur leader en solutions de confinement, de délivrance et de diagnostic des médicaments, a annoncé ses projets de publier les résultats financiers du deuxième trimestre 2024 le 6 août 2024 à 6h30 ET. L'entreprise organisera une conférence téléphonique et un webinaire le 6 août à 8h30 ET pour discuter des résultats. La direction fera référence à une présentation disponible sur le site Web de l'entreprise. Les participants peuvent s'inscrire à l'avance pour l'appel ou composer directement le numéro. Un webinaire en direct sera disponible, et l'appel sera archivé pendant trois mois sur le site Web des Relations Investisseurs de l'entreprise.

Stevanato Group (NYSE: STVN), ein führender Anbieter von Lösungen für die Arzneimittelverpackung, -abgabe und -diagnose, hat seine Pläne bekannt gegeben, die Finanzergebnisse des zweiten Quartals 2024 am 6. August 2024 um 6:30 Uhr ET zu veröffentlichen. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen. Die Geschäftsführung wird auf eine Präsentation verweisen, die auf der Website des Unternehmens verfügbar ist. Teilnehmer können sich im Voraus für die Konferenz anmelden oder direkt anrufen. Ein Live-Webcast wird verfügbar sein, und die Konferenz wird für drei Monate auf der Webseite der Investor Relations des Unternehmens archiviert.

Positive
  • None.
Negative
  • None.

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the second quarter of 2024 on Tuesday, August 6, 2024, at 6:30 a.m. (ET).

Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Tuesday, August 6, 2024, to discuss financial results. During the call, management will refer to a slide presentation which will be available on the morning of the call on the “Financial Results” page under the Company's Investor Relations section of its website.

Pre-registration: Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. We encourage participants to pre-register for the conference call using the following link: STVN conference call pre-registration.

Webcast: A live, listen-only webcast of the call will be available at the following link: STVN webcast.
Dial in: Those who are unable to pre-register may dial in by calling:

Italy:

+39 02 802 09 11

United Kingdom:

+44 1 212 818004

United States:

+1 718 705 8796

United States Toll Free:

+1 855 265 6958

Questions during the call: Participants who wish to ask questions during the call should use the HD webphone link: https://hditalia.choruscall.com/?$Y2FsbHR5cGU9MiZpbmZvPWNvbXBhbnk=.

Replay:

The webcast will be archived for three months on the Company’s Investor Relations section of its website.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions, as well as engineering solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug lifecycle from development to clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value-added solutions to clients. For more information, please visit www.stevanatogroup.com.

Investor Relations

Lisa Miles

lisa.miles@stevanatogroup.com

Media

media@stevanatogroup.com

Source: Stevanato Group S.p.A.

FAQ

When will Stevanato Group (STVN) release its Q2 2024 financial results?

Stevanato Group (STVN) will release its second quarter 2024 financial results on Tuesday, August 6, 2024, at 6:30 a.m. ET.

What time is Stevanato Group's (STVN) Q2 2024 earnings conference call?

Stevanato Group's (STVN) Q2 2024 earnings conference call is scheduled for Tuesday, August 6, 2024, at 8:30 a.m. ET.

How can investors participate in Stevanato Group's (STVN) Q2 2024 earnings call?

Investors can participate in Stevanato Group's (STVN) Q2 2024 earnings call by pre-registering, dialing in directly, or accessing the live webcast available on the company's website.

Where can investors find Stevanato Group's (STVN) Q2 2024 earnings presentation?

Investors can find Stevanato Group's (STVN) Q2 2024 earnings presentation on the 'Financial Results' page under the company's Investor Relations section of its website on the morning of the call.

Stevanato Group S.p.A.

NYSE:STVN

STVN Rankings

STVN Latest News

STVN Stock Data

5.68B
48.55M
2.04%
114.09%
1.34%
Medical Instruments & Supplies
Healthcare
Link
United States of America
Piombino Dese